Related Experiment Video
Updated: Dec 25, 2025
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[When COVID-19 encounters interstitial lung disease: challenges and management]
1Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing 100029, China.
Distinguishing between COVID-19 and interstitial lung disease (ILD) is challenging due to similar lung injury patterns. Comprehensive analysis of clinical, imaging, and laboratory data is crucial for accurate diagnosis and management of these respiratory conditions.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- COVID-19, a novel coronavirus pneumonia, emerged in late 2019, presenting with lung injury patterns similar to interstitial lung disease (ILD).
- The overlapping clinical and radiological features between COVID-19 and ILD complicate differential diagnosis, particularly in cases of new-onset ILD or acute exacerbations.
Purpose of the Study:
- To discuss the differential diagnosis and management strategies for COVID-19 and ILD.
- To provide clinical guidance for distinguishing between these two conditions presenting with similar respiratory symptoms.
Main Methods:
- Review of clinical characteristics, imaging findings, and serological/pathogenic test results for COVID-19 and ILD.
- Comparative analysis of lung injury and repair mechanisms in both diseases.
Main Results:
- Differential diagnosis requires a multifaceted approach, integrating epidemiological history, onset characteristics, clinical presentation, and diagnostic test results.
- Similarities in lung injury and repair processes between COVID-19 and ILD necessitate careful evaluation to avoid misdiagnosis.
Conclusions:
- Accurate diagnosis of COVID-19 versus ILD relies on comprehensive assessment of multiple factors.
- Effective management strategies depend on precise differential diagnosis, highlighting the need for clinicians to integrate diverse data points.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: